DecImmune Therapeutics

Business Data, Corporate Office and Headquarter Address

About

DecImmune Therapeutics is Drug Discovery in United States that focus on infarction conditions business. Founded in 2001. They cover business area such as developer, tissue damage, organ function, vascular inflammatory disease, an innate IgM-mediate auto-immune pathway, healthcare professional, diabetic nephropathy, renal ischemia, myocardial infarction condition.

Business Type

Drug Discovery

Country

United States

Founded

2001
( 23 years old in 2024 )

Company Focus

Infarction Conditions

Website

-

Corporate Office and Headquarter Office address:

55 Cambridge Parkway
Suite 301
Cambridge, MA 02142
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developertissue damageorgan functionvascular inflammatory diseasean innate IgM-mediate auto-immune pathwayhealthcare professionaldiabetic nephropathyrenal ischemiamyocardial infarction condition

* We use standard office opening hours in near DecImmune Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

DecImmune Therapeutics Frequently Asked Questions

What or who is DecImmune Therapeutics?

DecImmune Therapeutics is Drug Discovery business from United States that founded in 2001 (23 years old in 2024), DecImmune Therapeutics business is focusing on Infarction Conditions.

Where is DecImmune Therapeutics headquarter and corporate office address?

DecImmune Therapeutics headquarter office and corporate office address is located in 55 Cambridge Parkway Suite 301 Cambridge, MA 02142 United States.

Where is DecImmune Therapeutics country origins?

DecImmune Therapeutics was founded in United States.

What is Infarction Conditions business focus on?

In 2024, DecImmune Therapeutics is currently focus on infarction conditions sector.

Infarction Conditions Business Interest from Google Trend

Above is snippet of Google Trends for "infarction conditions" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with DecImmune Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.